Recruiting
Herpes ophthalmic+1
RecruitingTesting Aganirsen Eye Drops in Patients with Corneal Blood Vessel Growth from Herpes Eye Disease Before Corneal Transplant Surgery
Registered drug
Testing Aganirsen Eye Drops in Patients with Corneal Blood Vessel Growth from Herpes Eye Disease Before Corneal Transplant Surgery
Registered drug
- Disease:Herpes ophthalmicCorneal neovascularisation
- Substances:AganirsenOfloxacin+1
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Aganirsen
- Sponsor:University Of Cologne
